JPRN-jRCT1080222856招募中Unknown
Post-Marketing Surveillance of Lenvima Capsule in patients with unresectable thyroid cancer in Japan (All case study)
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Unresectable thyroid cancer
排除标准
- •1)Corresponding to contraindication of Lenvima Capsule
- •2)Not applicable to indications of Lenvima Capsule
研究者
相似试验
招募中
不适用
Post-marketing surveillance of AMYViD InjectioVisualization of amyloid beta plaque in the brain of patients with cognitive dysfunction suspected oJPRN-jRCT2031220067Kazunori Bando500
招募中
Unknown
VANFLYTA Tablet Post-marketing Surveillance StudyRelapsed or refractory acute myeloid leukemia with FLT3-ITD mutation positiveJPRN-jRCT1080224910DAIICHI SANKYO CO., LTD.210
未知
Unknown
Post-marketing surveillance of administration of botulinum toxin type B(NerBloc)-investigation of the clinical condition in patients with changing from botulinum toxin type Acervical dystoniaJPRN-jRCT1080222128Eisai Co., Ltd.150
已完成
Unknown
Post-marketing surveillance of administration of botulinum toxin type B(NerBloc)-Investigation of the clinical condition and safety in patients with cervical dystoniacervical dystoniaJPRN-jRCT1080222127Eisai Co., Ltd.
已完成
Unknown
Post-marketing surveillance of DIACOMITCapsule, Powder for Oral SuspensioDravet SyndromeJPRN-jRCT1080225085Meiji Seika Pharma Co., Ltd.300